Abstract
Evidence for risk factors for pressure ulceration was graded as follows: A: supported by two or more prospective studies; B: supported by prospective or retrospective studies; C: anecdotal evidence, case reports or studies which do not all support the risk factor but consensus expert opinion provides support, or D: conflicting evidence not supported by consensus expert opinions. Among the Pressure Ulcer Interest Subcommittee of the Australian Wound Management Association (AWMA), expert consensus was reached: no risk factors were supported by evidence graded A; reduced mobility and activity, shear and friction and older age were supported by evidence graded B; moisture (especially faecal incontinence), nutritional factors, vitamin C status, oxygen delivery, diabetes, dry skin and previous pressure ulceration were supported by evidence rated C, and a rating of D given evidence supporting zinc status, male gender, race, temperature (skin and core), cancer and other chronic illnesses, recent hospital transfer, use of antipsychotic medications and psycho-social factors. Evidence-based preventive approaches will be most cost-effective but more data must be gathered to determine whether evidence for risk factors not currently well-supported can be strengthened.

Abstract
This is a review of the reintroduction of larva therapy (LT) into modern wound care. Subjects addressed include the relevant larval biology, laboratory requirements for production for clinical use, patient selection, dressing techniques, clinical results and prospects for the future.

Abstract

Abstract
The wound management department (WMD) of the Sydney Adventist Hospital undertook a 3-month evaluation of a new cavity wound dressing – AcryDerm Strands ™. When utilised on a variety of wounds, including dehiscence, pressure ulceration and fungating tumours, the product was found to provide clinical, as well as patient comfort and cost-saving, advantages.